Drug application
CAPASTAT SULFATE (CAPREOMYCIN SULFATE)
Drugs@FDA NDA 050095 · EPIC PHARMA LLC
Key facts
| Drug name | CAPASTAT SULFATE |
|---|---|
| Active ingredients | CAPREOMYCIN SULFATE |
| Application type | NDA |
| Application number | 050095 |
| Company | EPIC PHARMA LLC |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission status date | Jun 2, 1971 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: